| Dr Kristi Ammons Dillard, DMD | |
|
3070 Highway 17 North, Suite 101, Mount Pleasant, SC 29466 | |
| (843) 849-9990 | |
| (843) 849-9656 |
| Full Name | Dr Kristi Ammons Dillard |
|---|---|
| Gender | Female |
| Speciality | Dentist - General Practice |
| Location | 3070 Highway 17 North, Mount Pleasant, South Carolina |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235328279 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223G0001X | Dentist - General Practice | 3476 (South Carolina) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kristi Ammons Dillard, DMD 3070 Highway 17 North, Suite 101, Mount Pleasant, SC 29466-8958 Ph: (843) 849-9990 | Dr Kristi Ammons Dillard, DMD 3070 Highway 17 North, Suite 101, Mount Pleasant, SC 29466 Ph: (843) 849-9990 |
News Archive
According to the latest figures from the UK's Office of National Statistics, a range of factors have been identified to assist in the complex calculation of national well-being and happiness in general.
Life Technologies Corporation today announced the first end-to-end sequencing solution for exon-level copy number variation analysis, which combines the Ion Reporter CNV data analysis workflow, the Ion AmpliSeq Exome Kit and the Ion Proton® System.
Tolerx, Inc., a biopharmaceutical company developing novel therapies to treat autoimmune diseases and cancer by modulating T cell activity, today announced the initiation of a confirmatory Phase 3 clinical trial to further evaluate otelixizumab in autoimmune new-onset type 1 diabetes. The confirmatory Phase 3 clinical trial is called DEFEND-2 (Durable-Response Therapy Evaluation For Early or New-Onset Type 1 Diabetes) and immediately follows successful completion of enrollment in the initial Phase 3 clinical trial, DEFEND-1, with results from DEFEND-1 expected in the first half of 2011.
Researchers in the United States and Canada warn that more attention needs to be paid to the role that structural variants and recombination in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have played in the evolutionary history of the virus.
MICARDIS(R) (telmisartan) has received Health Canada approval to reduce the risk of non-fatal stroke or non-fatal myocardial infarction in patients 55 years or older at high risk of developing major cardiovascular events who cannot tolerate an angiotensin converting enzyme (ACE) inhibitor.
› Verified 6 days ago
Dr. Gregory William Bottone, D.M.D. Dentist Medicare: Not Enrolled in Medicare Practice Location: 924 Tall Pine Rd, Mount Pleasant, SC 29464 Phone: 843-884-4486 Fax: 843-881-4852 | |
Dr. Mathew James Swenson, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 2023 Highway 41, Mount Pleasant, SC 29466 Phone: 843-518-3701 | |
Dr. David Allan Bodie, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 929 Bowman Rd Ste 100, Mount Pleasant, SC 29464 Phone: 843-971-0661 Fax: 843-971-5219 | |
Dr. Edward Alex Kusek, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 317 Wingo Way Ste 301, Mount Pleasant, SC 29464 Phone: 843-884-2021 | |
Dr. Michael Francis Cuenin, DMD Dentist Medicare: Medicare Enrolled Practice Location: 682 Johnnie Dodds Blvd., Suite 102, Mount Pleasant, SC 29464 Phone: 843-849-9044 Fax: 843-849-7493 | |
Dr. Steve Crossland, D.M.D. Dentist Medicare: Not Enrolled in Medicare Practice Location: 929 Bowman Rd, Suite A, Mount Pleasant, SC 29464 Phone: 843-849-9616 Fax: 843-971-5219 | |
Dr. Nathan Mcketa, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 3435 Salterbeck St, Mount Pleasant, SC 29466 Phone: 843-971-6864 Fax: 843-971-6501 |